je.st
news
Tag: drug patent
U.S. drug company challenges Ottawa's ability to control patent drug prices
2015-09-25 22:24:06| Biotech - Topix.net
Canada's ability to control the price of patented drug prices could be at risk after a U.S. company challenged the constitutionality of the federal regulator's ability to order a price cut for a costly treatment for a rare genetic condition. Alexion Pharmaceuticals has filed a lawsuit in Federal Court against Canada's Patented Medicine Prices Review Board that determined that the price of Soliris, which has been dubbed the world's costliest drug, is "excessive."
Tags: company
control
prices
ability
Federal court backs patent protecting Eli Lilly cancer drug
2015-08-26 16:29:15| Biotech - Topix.net
Shares of Eli Lilly rose Wednesday in premarket trading a day after the drugmaker said a federal court upheld a patent protecting one of its top-selling drugs, the cancer treatment Alimta. The Indianapolis company said Tuesday after markets closed that the U.S. District Court for the Southern District of Indiana ruled in Lilly's favor regarding the infringement of a vitamin regimen patent for Alimta.
Tags: court
federal
drug
cancer
AstraZeneca's patent on asthma drug invalidated by US court
2015-02-16 06:34:56| Biotech - Topix.net
A U.S. federal judge ruled late on Friday that AstraZeneca PLC's patent on its Pulmicort Repsules treatment for asthma was invalid, opening up the market to a second, cheaper generic version. NEW YORK: A U.S. federal judge ruled late on Friday that AstraZeneca PLC's patent on its Pulmicort Repsules treatment for asthma was invalid, opening up the market to a second, cheaper generic version.
Indianapolis court backs patent for Lilly cancer drug Alimta
2014-04-12 08:38:12| Agriculture - Topix.net
A federal court has upheld the patent that protects Eli Lilly and Co.' s lung-cancer treatment from generic competition until 2022.
Tags: court
drug
cancer
patent
Indianapolis court backs patent for Lilly cancer drug Alimta
2014-04-07 01:16:09| Agriculture - Topix.net
A federal court has upheld the patent that protects Eli Lilly and Co.' s lung-cancer treatment from generic competition until 2022.
Tags: court
drug
cancer
patent